David Armstrong has been a health reporter for decades, so he thought he was prepared for the cost of being sick in America when he was diagnosed with cancer at the beginning of 2023. But even he was shocked to find that Revlimid, the drug that keeps his incurable multiple myeloma somewhat at bay, costs almost $1,000 for a daily pill. Here’s his story for @ProPublica about how it came to cost so much and why the price keeps being hiked. When Mark Alles, president of the drug’s manufacturer Celgene, appeared before the House Oversight Committee in 2020, he was quizzed by then-Rep. Katie Porter (D-Calif.). She concluded: “The drug didn’t get any better. The cancer patients didn’t get any better. You just got better at making money. You just refined your skills at price gouging.”
https://www.propublica.org/article/revlimid-price-cancer-celgene-drugs-fda-multiple-myeloma
#Health #Pharma #PharmaceuticalCompanies #Medication #Drugs #Cancer #Newstodon #NewstodonFriday #FollowFriday